Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity

Yeun-po Chiang, Zhiqiang Li, Yang Chen, Yu Cao, Xian‐Cheng JiangJournal of Biological Chemistry 2021 · DOI

TL;DR

Researchers have identified sphingomyelin synthases 1 and 2 (SMS1 and SMS2) as the long-sought mammalian enzymes responsible for phosphatidylcholine phospholipase C (PC-PLC) activity. This discovery bridges a significant gap in our understanding of lipid metabolism, revealing that these enzymes possess dual roles in both sphingomyelin synthesis and PC hydrolysis, impacting cellular levels of key lipids like PC and DAG.

What Problem Does This Paper Address?

For decades, scientists have known that mammalian cells possess a phosphatidylcholine phospholipase C (PC-PLC) activity. This enzyme is crucial for breaking down phosphatidylcholine (PC), a major component of cell membranes, into diacylglycerol (DAG) and phosphocholine. This process is vital for maintaining cell membrane integrity and function, and is implicated in various cellular processes like growth, differentiation, and apoptosis. However, despite extensive research and the identification of bacterial PC-PLCs, the specific mammalian protein(s) responsible for this activity remained elusive. This knowledge gap meant that studies on PC-PLC function and regulation in mammals largely relied on the use of small-molecule inhibitors, like D609, which also happened to inhibit sphingomyelin synthases (SMS). This observation, coupled with the structural similarity of SMS enzymes to known phospholipases, led researchers to hypothesize that SMS enzymes themselves might possess PC-PLC activity.

Methods

The researchers employed a multi-pronged approach to investigate their hypothesis:

  • In vitro enzymatic assays: They used purified recombinant forms of SMS1, SMS2, and a related protein, SMSr, to test their enzymatic activities. These assays involved incubating the purified proteins with labeled substrates (like NBD-PC or 14C-PC) and measuring the production of specific products (like NBD-DAG or 14C-DAG) using thin-layer chromatography (TLC). They also measured the production of phosphocholine, another product of PC-PLC activity, using a specific assay kit.
  • Cell-based assays: They transfected Cos7 cells with flag-tagged versions of SMS1, SMS2, and SMSr. They then immunoprecipitated these tagged proteins and performed similar enzymatic assays to assess their activity within a cellular context.
  • Animal models: To study the in vivo relevance, they generated genetically modified mice. Specifically, they created liver-specific Sms1/global Sms2 double knockout (dKO) mice and further crossed them with Smsr knockout mice to create triple knockout (tKO) mice. These mice were used to assess the impact of SMS deficiency on PC-PLC activity and lipid levels in liver and plasma.
  • Adenovirus-mediated gene delivery: To confirm the role of SMS1 and SMS2 in vivo, they used adenoviruses to re-express Sms1 and Sms2 in the livers of the tKO mice and then measured the resulting PC-PLC activity and lipid profiles.
  • Michaelis-Menten kinetics: To quantify the enzymatic properties of SMS1 and SMS2, they performed kinetic studies by varying the concentration of PC and measuring the reaction rates.

Datasets

Not discussed in the paper. The study relies on enzymatic assays and lipid measurements from cell cultures and animal models, rather than pre-existing datasets.

Key Insights and Ideas

  • Dual Functionality Revealed: The most significant insight is that SMS1 and SMS2 are not just sphingomyelin synthases but also possess significant PC-PLC activity. This dual functionality was previously unrecognized and fundamentally changes our understanding of these enzymes.
  • Bridging the PC-PLC Gap: This work finally identifies the mammalian enzymes responsible for PC-PLC activity, a long-standing mystery in lipid biochemistry. This opens the door for more targeted research into the physiological roles of PC-PLC.
  • D609's Dual Inhibition Explained: The finding that D609 inhibits both SMS and PC-PLC activity is now explained by the fact that SMS1 and SMS2 are responsible for both.
  • SMSr's Specificity: The study clearly differentiates SMSr, showing it has PE-PLC activity but not significant PC-PLC activity, highlighting the distinct roles within the SMS family.
  • In Vivo Relevance Confirmed: The use of knockout mice and subsequent gene re-expression experiments strongly supports the in vivo relevance of SMS1 and SMS2 in regulating PC and DAG levels.

Key Results

  • Purified recombinant SMS1 and SMS2, but not SMSr, exhibited PC-PLC activity in vitro, hydrolyzing PC to produce DAG and phosphocholine.
  • SMS1 and SMS2 also showed PC-PLC activity when expressed in Cos7 cells and immunoprecipitated.
  • Liver-specific Sms1/global Sms2 double-KO mice showed significantly reduced liver PC-PLC activity compared to wild-type controls.
  • These dKO mice also displayed altered steady-state levels of PC and DAG in the liver.
  • Re-expression of Sms1 or Sms2 in triple-KO mice via adenovirus significantly increased liver PC-PLC activity.
  • Michaelis-Menten kinetics revealed SMS1 and SMS2 have comparable PC-PLC activities with Km values in the micromolar range, which increased in the presence of ceramide.

Limitations and Future Work

  • Extent of in vivo PC-PLC activity: While the study demonstrates SMS1 and SMS2's PC-PLC activity in vitro and in vivo, further work is needed to determine the precise extent to which this activity is mediated by their PC-PLC function in vivo, as other enzymes might also contribute to DAG and P-choline production.
  • Biological and pathological functions: The authors emphasize that the biological and pathological functions of SMS-mediated PC-PLC activity warrant further investigation. This includes understanding how this dual activity impacts various cellular processes and disease states.
  • Divergent DAG effects: The paper notes that DAG generated from different sources can have variable effects on protein kinase C (PKC) activation. The specific impact of PC-PLC-derived DAG on cellular signaling pathways requires further exploration.
  • Global KO mice generation: The authors mention that obtaining global Sms1/ Sms2/ Smsr triple KO mice by simply crossing single KO mice was not feasible, suggesting potential complexities in generating such models.

Summary updated

Abstract

Many studies have confirmed the enzymatic activity of a mammalian phosphatidylcholine (PC) phospholipase C (PLC) (PC-PLC), which produces diacylglycerol (DAG) and phosphocholine through the hydrolysis of PC in the absence of ceramide. However, the protein(s) responsible for this activity have never yet been identified. Based on the fact that tricyclodecan-9-yl-potassium xanthate can inhibit both PC-PLC and sphingomyelin synthase (SMS) activities, and SMS1 and SMS2 have a conserved catalytic domain that could mediate a nucleophilic attack on the phosphodiester bond of PC, we hypothesized that both SMS1 and SMS2 might have PC-PLC activity. In the present study, we found that purified recombinant SMS1 and SMS2 but not SMS-related protein have PC-PLC activity. Moreover, we prepared liver-specific Sms1/global Sms2 double-KO mice. We found that liver PC-PLC activity was significantly reduced and steady-state levels of PC and DAG in the liver were regulated by the deficiency, in comparison with control mice. Using adenovirus, we expressed Sms1 and Sms2 genes in the liver of the double-KO mice, respectively, and found that expressed SMS1 and SMS2 can hydrolyze PC to produce DAG and phosphocholine. Thus, SMS1 and SMS2 exhibit PC-PLC activity in vitro and in vivo.
BibTeX
@article{chiang2021sphingomyelin,
  author = {Yeun-po Chiang and Zhiqiang Li and Yang Chen and Yu Cao and Xian‐Cheng Jiang},
  title = {{Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity}},
  journal = {Journal of Biological Chemistry},
  year = {2021},
  doi = {10.1016/j.jbc.2021.101398},
}
Figure